Clinical Trials Browser

Phase 3 × Metastatic Castration-Resistant Prostate Cancer × 30 days × Clear all

NCT06629779 2026-03-04

A Study to Learn How PF-06821497 (Mevrometostat) Works in Men With Metastatic Castration-resistant Prostate Cancer.

Phase 3 Recruiting

Metastatic Castration-Resistant Prostate Cancer